Competitor Analysis: Hepatitis Vaccines
Product description
The present Competitive Intelligence report about Hepatitis Vaccines provides a competitor evaluation in the field of marketed and novel prophylactic vaccines against hepatitis A, hepatitis B, hepatitis A and B, hepatitis C and hepatitis E viruses. Product description considers use of adjuvants and preservatives. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently marketed vaccines and active projects in research and development for prophylaxis of hepatitis A, B, C and E. In addition, the report lists company-specific product portfolios and R&D pipelines of hepatitis vaccines on the market and in R&D. Competitor projects are listed in a tabular format providing information on:
Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
Index
Single Hepatitis A Virus Vaccines
Dual Hepatitis A and B Virus Vaccines
Single Hepatitis B Virus Vaccines
Combination Vaccines including HAV Vaccines
Combination Vaccines including HBV Vaccines
Hepatitis C Virus Vaccines
Hepatitis E Virus Vaccines
Corporate Hepatitis Vaccine Product Portfolios and R&D Pipelines
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The present Competitive Intelligence report about Hepatitis Vaccines provides a competitor evaluation in the field of marketed and novel prophylactic vaccines against hepatitis A, hepatitis B, hepatitis A and B, hepatitis C and hepatitis E viruses. Product description considers use of adjuvants and preservatives. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently marketed vaccines and active projects in research and development for prophylaxis of hepatitis A, B, C and E. In addition, the report lists company-specific product portfolios and R&D pipelines of hepatitis vaccines on the market and in R&D. Competitor projects are listed in a tabular format providing information on:
Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
Index
Single Hepatitis A Virus Vaccines
Dual Hepatitis A and B Virus Vaccines
Single Hepatitis B Virus Vaccines
Combination Vaccines including HAV Vaccines
Combination Vaccines including HBV Vaccines
Hepatitis C Virus Vaccines
Hepatitis E Virus Vaccines
Corporate Hepatitis Vaccine Product Portfolios and R&D Pipelines
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
